SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32: 9981006.
  • 2
    Wigley FM. Raynaud's phenomenon. N Engl J Med 2002; 347: 10017.
  • 3
    Mannarino E, Pasqualini L, Fedeli F, Scricciolo V, Innocente S. Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon. Angiology 1994; 45: 3742.
  • 4
    Blockmans D, Beyens G, Verhaeghe R. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 1996; 15: 14853.
  • 5
    Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma [letter]. Arthritis Rheum 2001; 44: 7356.
  • 6
    Bukhari M, Hollis S, Moore T, Jayson MI, Herrick AL. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology (Oxford) 2000; 39: 50612.
  • 7
    Leteurtre E, Hachulla E, Janin A, Hatron PY, Brouillard M, Devulder B. Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 1994; 15: 8007.
  • 8
    Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55: 50712.
  • 9
    Sarrat P. Periungual capillaroscopy in children with scleroderma and dermatomyositis. J Mal Vasc 1983; 8: 1757.
  • 10
    Bongard O, Bounameaux H, Miescher PA, de Moerloose P. Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 1995; 4: 1424.
  • 11
    Sulli A, Pizzorni C, Cutolo M. Nailfold videocapillaroscopy abnormalities in patients with antiphospholipid antibodies [letter]. J Rheumatol 2000; 27: 15746.
  • 12
    Raynaud M. Thése de Médicine: De l'asphyxie locale et de la gangréne des extremités. Paris: Leclerc; 1862.
  • 13
    Hutchinson H. Raynaud's phenomenon. Presse Med 1901; 71: 4035.
  • 14
    Lombard WP. The blood pressure in the arterioles, capillaries, and small veins of the human skin. Am J Physiol 1911; 29: 35562.
  • 15
    Weiss W. Demonstration von Hautkapillarveraenderungen bei akuter Nephritis. Med Bl Landerver 1916; LXXXVI: 383.
  • 16
    Brown GE, O'Leary PA. Skin capillaries in scleroderma. Arch Intern Med 1925; 36: 7388.
  • 17
    Allen EV, Brown JE. Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 1932; 22: 187200.
  • 18
    Hunt JH. The Raynaud's phenomenon: a critical review. QJM 1936; 5: 399444.
  • 19
    Müller O. Die feinsten blutgefaessen des menschen. Stuttgart: E. Enke Verlag; 1939.
  • 20
    Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 1973; 16: 61928.
  • 21
    Maricq HR, Downey JA, LeRoy EC. Standstill of nailfold capillary blood flow during cooling in scleroderma and Raynaud's syndrome. Blood Vessels 1976; 13: 33849.
  • 22
    Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 15560.
  • 23
    Silman A, Holligan S, Brennan P, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ 1990; 301: 5902.
  • 24
    Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Biro C, et al. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol 1997; 24: 87989.
  • 25
    LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 4858.
  • 26
    Planchon B, Pistorius MA, Beurrier P, de Faucal P. Primary Raynaud's phenomenon: age of onset and pathogenesis in a prospective study of 424 patients. Angiology 1994; 45: 67786.
  • 27
    Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990; 16: 1130.
  • 28
    Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595600.
  • 29
    Zufferey P, Depairon M, Chamot AM, Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities: a six-year follow-up study. Clin Rheumatol 1992; 11: 53641.
  • 30
    Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002; 51: 351723.
  • 31
    Emerson GG, Segal SS. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: role in vasomotor control. Circ Res 2000; 87: 4749.
  • 32
    Bollinger A, Jäger K, Roten A, Timeus C, Mahler F. Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch 1979; 382: 13743.
  • 33
    Grassi W, Core P, Carlino G, Cervini C. Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 1994; 37: 38490.
  • 34
    Bollinger A, Jäger K, Siegenthaler W. Microangiopathy of progressive systemic sclerosis: evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 1986; 146: 15415.
  • 35
    Grassi W, Felder M, Thuring-Vollenweider U, Bollinger A. Microvascular dynamics at the nailfold in rheumatoid arthritis. Clin Exp Rheumatol 1989; 7: 4753.
  • 36
    Carter SA, Dean E, Kroeger EA. Apparent finger systolic pressure during cooling in patients with Raynaud's syndrome. Circulation 1988; 77: 98896.
  • 37
    Grassi W, Core P, Cervini C. Increased capillary permeability in systemic sclerosis: help or hindrance? Ann Rheum Dis 1996; 55: 6036.
  • 38
    Colwell JA, Halushka PV, Sarji KE, Lopes-Virella MF, Sagel J. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med 1979; 139: 22530.
  • 39
    Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 115965.
  • 40
    Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195205.
  • 41
    Ryan TJ. Microcirculation in psoriasis: blood vessels, lymphatics and tissue fluid. Pharmacol Ther 1980; 10: 2764.
  • 42
    Houtman PM, Kallenberg CGM, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon: an analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13: 55663.
  • 43
    Jayson MIV. The micro-circulation in systemic sclerosis. Clin Exp Rheumatol 1984; 2: 8591.
  • 44
    Chen ZY, Silver RM, Ainsworth SK, Dobson RL, Rust P, Maricq HR. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77: 81222.
  • 45
    Blann AD, Illingworth K, Jayson MIV. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 132530.
  • 46
    Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990; 16: 7591.
  • 47
    Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 1839.
  • 48
    Lee P, Sarkozi J, Bookman AA, Keystone EC, Armstrong SK. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon. J Rheumatol 1986; 13: 5649.
  • 49
    Von Bierbrauer AF, Mennel HD, Schmidt JA, von Wichert P. Intravital microscopy and capillaroscopically guided nail fold biopsy in scleroderma. Ann Rheum Dis 1996; 55: 30510.
  • 50
    Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust N Z J Med 1995; 25: 68894.
  • 51
    Andrade LEC, Gabriel A Jr, Assad RL, Ferrari AJL, Atra E. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990; 20: 2131.
  • 52
    Bollinger A, Fagrell B. Collagen vascular disease and related disorders. In: BollingerA, FagrellB, editors. Clinical capillaroscopy. Cambridge (MA): Hogrefe & Huber; 1990. p. 12143.
  • 53
    Nobili F, Cutolo M, Sulli A, Castaldi A, Sardanelli F, Accardo S, et al. Impaired quantitative cerebral blood flow in scleroderma patients. J Neurol Sci 1997; 152: 6371.
  • 54
    Sulli A, Seriolo B, Savarino V, Cutolo M. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis [letter]. J Rheumatol 2000; 27: 18201.
  • 55
    Cutolo M, Nobili F, Sulli A, Pizzorni C, Briata M, Faelli F, et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 2000; 39: 136673.
  • 56
    Filaci G, Cutolo M, Basso M, Murdaca G, Derchi L, Gianrossi R, et al. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A [letter]. Rheumatology (Oxford) 2001; 40: 14312.
  • 57
    Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002; 4: R11.
  • 58
    Grassi W, Medico PD, Izzo F, Cervini C. Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 2001; 30: 397402.